Pralurbactam

DB19437InvestigationalSmall molecule

Pralurbactam is under investigation in clinical trial NCT06633718 (Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI).

Chemical structure of Pralurbactam
Mechanism
Curator reviewed
Formula / weight
C10H18N6O8S · 382.35 g/mol (avg)
Also known as
(1R,2S,5R)-2-[[[2-[[(Aminoiminomethyl)amino]oxy]ethoxy]amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl hydrogen sulfate · 1R,2S,5R)-2-{[2-(guanidinooxy)ethoxy]carbamoyl}-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate · Sulfuric acid, mono[(1R,2S,5R)-2-[[[2-[[(aminoiminomethyl)amino]oxy]ethoxy]amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester

Resolves to

Compound
UNIIGTP46AY74RCAS2163782-59-8ChEMBLCHEMBL5314477ChEBI759183PubChem155048066
Structure
InChIKeyHOJIPBUGHMYVQD-RQJHMYQMSA-NSMILES[H][C@]12C[N@]([C@@H](CC1)C(=O)NOCCONC(N)=N)C(=O)N2OS(O)(=O)=O
Targets
P00807blaZ

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Pralurbactam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In